Kentucky Clinical Trials Laboratory © 2013 | All Rights Reserved
Kentucky Clinical Trials Laboratory
201 E. Jefferson Street Louisville KY 40202 US +1.502.569.0337 email@example.com
Dr. Jortani is a Professor of Pathology and Laboratory Medicine at University of Louisville School of Medicine. He is a board certified clinical chemist and a practicing toxicologist. He is an Associate Director of University of Louisville’s Clinical Chemistry and Toxicology Laboratory. He has served as a representative of several national organizations in the area of laboratory medicine such as the American Association for Clinical Chemistry (AACC), American Board for Clinical Chemistry (ABCC) and the Commission on Accreditation in Clinical Chemistry (ComACC).
Dr. Jortani is a co-founder and the past chair of the Clinical Proteomics Division of the AACC. He is on the editorial boards of Clinica Chemica Acta and Clinical Proteomics, Therapeutic Drug Monitoring. His research interests are proteomics, detection and measurement of drugs, therapeutics and poisons, and the use of pharmacogenetics in pain management and for postmortem investigations. Working with other executive officers of the proteomics division and the National Cancer Institute, Dr. Jortani has been instrumental in establishing a memorandum of understanding (MOU) between AACC and the NCI.As the founder of KCTL, Dr. Jortani has served the diagnostic industry for over 20 years. He has secured several million dollars of funding for clinical research. He has been a co-inventor on at least 5 patent applications, all of which are various stages of discovery proceeding toward translation and novel diagnostics.
Dr. Jortani is also one of the leaders in the field of pharmacogenetics specifically focusing on personalized pain management and PGx-guided forensic toxicology investigations and pain management. As a liaison representing the AACC to the College of American Pathologists, he co-founded the first proficiency testing materials in the area of clinical pharmacogenetics. His efforts by participating in the writing of the Laboratory Medicine Practice Guidelines in Pharmacogenetics and his directing of clinical trials in this area will contribute to substantial advancement in this area.
Additional Websites associated with Dr. Jortani:
University of Louisville School of Medicine, Department of Pathology & Laboratory
Saeed A. Jortani Ph.D., DABCC
68th AACC Annual Scentific Meeting & Clinical Lab Expo
July 31- August 4, 2016 Pennsylvania Convention Center Philadelphia, PA
LINE 1 Open Reading Fram 1 (ORF1) Protein Concentrations in Men with Porstace Cancer
K. Hosseinnejad, J.L. Balien, L. Isaacs, K.S. Ramos, S.A. Jortani. Univsersity of Louisville, KY, First Urology, Jeffersonville, IN, Univsersity of Arizona, Tucson, AZ
Multicenter characterization of a fully automated electrochemiluminescence immunoassay for the quantitation of serum periostin, a pormising biomarker for guiding treatment in Type 2 asthma
R.H. Christenson, S.A. Jortani, R.E. Ostlund, R. Kolm, F. Krause, R.P. Laubender, S. Palme. University of Maryland Medical Center, Baltimore, MD, University of Louisville, Louisville, KY, Washington University in St. Louis, MO, Roche Diagnostics, Penzberg, Germany
Clinical Performance of Elecsys Anti-HCV II in Subjects with Increased Risk of Hepatitis
T. Eden, R. Ostlund Jr., P. Jones, S. Jortani, M. Lessig, E. Schiff, J. Layton, R. Dworschack. Core Laboratory for Clinical Studies, Washington University, St. Louisv, MO, Southbend Medical Foundation, Southbend, IN, Kentucky Clinical Trials Laboratory, Louisville, KY, University of Louisville, Louisville, KY, Formerly Nationwide Laboratory Services, Fort Lauderdale, FL, University of Miami, Miami FL, Roche Diagnostics Inc., Indianapolis, IN